GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Recbio Technology Co Ltd (FRA:G93) » Definitions » Price-to-Funds-From-Operations

Jiangsu Recbio Technology Co (FRA:G93) Price-to-Funds-From-Operations : (As of Dec. 14, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Jiangsu Recbio Technology Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Jiangsu Recbio Technology Co Business Description

Comparable Companies
Traded in Other Exchanges
Address
No. 888 Yaocheng Avenue, Medical High-tech District, Jiangsu Province, Taizhou, CHN
Jiangsu Recbio Technology Co Ltd is a vaccine company dedicated to the development and commercialization of safer and more effective vaccines to address the far-unmet public needs. Hygiene needs. The company focuses on the R&D of HPV vaccine candidates. The company's vaccine portfolio currently consists of 12 vaccines, including three strategic products, namely REC603, a recombinant HPV 9-valent vaccine under phase III clinical trial.